Prognostic Value of Red Blood Cell Distribution Width in Transcatheter Aortic Valve Replacement Patients

Abstract

Objective

Elevated red blood cell distribution width (RDW) level has been shown to be associated with poor outcomes in patients with cardiovascular disease. Limited data are available regarding the prognostic value of RDW in transcatheter aortic valve replacement (TAVR) patients. Therefore, we aimed to investigate the impact of RDW variation on outcomes of TAVR patients.

Methods

From March 20, 2012, to February 20, 2020, the pre-TAVR RDW levels of 1,163 consecutive TAVR patients were examined. Receiver operating curves were set to define the most accurate cut-point, which was subsequently validated in our validation set. Associations of RDW levels with early and long-term outcomes were investigated.

Results

A total of 988 patients were eligible for the analysis. Patients with 30-day, 1-year, and 7-year mortality had significantly higher pre-TAVR RDW levels (15.8% [12.9-19.1] vs 14.7% [11.6-26.3], P = 0.01; 16% [12.3-26.3] vs 14.7% [11.6-24.3], P < 0.001; 15.6% [12.3-26.3] vs 14.6% [11.6-24.3], P < 0.001, respectively). A RDW of 14.5% was found as the most sensitive and specific cut-point for mortality at 1 and 7 years (HR = 2.6, 95% CI: 1.6-4.2, P < 0.001; HR = 1.8, 95% CI: 1.3-2.4, P < 0.001), with mortality of 22% versus 10% at 1 year (P < 0.001) and 37% versus 27% at 7 years (P < 0.001) in patients with RDW ≥14.5% versus those with RDW <14.5%.

Conclusions

RDW is an important prognostic factor in TAVR patients. A RDW level higher than 14.5% is significantly associated with post-TAVR early and late mortality. RDW levels should be incorporated into current risk assessment models as an additional variable to predict post-TAVR outcomes.

Keywords

blood cell distribution width RDW TAVR

Get full access to this article

View all access options for this article.

References

Leon

MB.

Smith

CR.

Mack

et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597–1607.20961243

Popma

JJ.

Adams

DH.

Reardon

et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol 2014; 63: 1972–1981.24657695

Kolte

Vlahakes

GJ.

Palacios

et al. Transcatheter versus surgical aortic valve replacement in low-risk patients. J Am Coll Cardiol 2019; 74: 1532–1540.31537261

D'Ascenzo

Ballocca

Moretti

et al. Inaccuracy of available surgical risk scores to predict outcomes after transcatheter aortic valve replacement. J Cardiovasc Med 2013; 14: 894–898.23877207

Watanabe

Hayashida

Lefèvre

et al. Is EuroSCORE II better than EuroSCORE in predicting mortality after transcatheter aortic valve implantation? Catheter Cardiovasc Interv 2013; 81: 1053–1060.23074135

Salvagno

GL.

Sanchis-Gomar

Picanza

et al. Red blood cell distribution width: a simple parameter with multiple clinical applications. Crit Rev Clin Lab Sci 2015; 52: 86–105.25535770

Felker

GM.

Allen

LA.

Pocock

et al. Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank. J Am Coll Cardiol 2007; 50: 40–47.17601544

Zalawadiya

SK.

Veeranna

Niraj

et al. Red cell distribution width and risk of coronary heart disease events. Am J Cardiol 2010; 106: 988–993.20854962

Magri

CJ.

Chieffo

Latib

et al. Red blood cell distribution width predicts one-year mortality following transcatheter aortic valve implantation. Int J Cardiol 2014; 172: 456–457.24529824

10.

Szekely

Finkelstein

Bazan

et al. Red blood cell distribution width as a prognostic factor in patients undergoing transcatheter aortic valve implantation. J Cardiol 2019; 74: 212–216.31060955

11.

Aung

Dworakowski

Byrne

et al. Progressive rise in red cell distribution width is associated with poor outcome after transcatheter aortic valve implantation. Heart 2013; 99: 1261–1266.23735935

12.

Baumgartner

Falk

Bax

et al. ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J 2017; 2017: 2739–2791.

13.

Otto

CM.

Kumbhani

DJ.

Alexander

et al. ACC expert consensus decision pathway for transcatheter aortic valve replacement in the management of adults with aortic stenosis: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2017; 2017: 1313–1346.

14.

Collas

VM.

Paelinck

BP.

Rodrigus

et al. Red cell distribution width improves the prediction of prognosis after transcatheter aortic valve implantation. Eur J Cardiothorac Surg 2016; 49: 471–477.25913826

15.

Muhlestein

JB.

Lappe

DL.

Anderson

et al. Both initial red cell distribution width (RDW) and change in RDW during heart failure hospitalization are associated with length of hospital stay and 30-day outcomes. Int J Lab Hematol 2016; 38: 328–337.27121354

16.

Skjelbakken

Lappegård

Ellingsen

et al. Red cell distribution width is associated with incident myocardial infarction in a general population: the Tromsø Study. J Am Heart Assoc 2014; 3: e001109.25134681

17.

Gul

Uyarel

Ergelen

et al. The relationship between red blood cell distribution width and the clinical outcomes in non-ST elevation myocardial infarction and unstable angina pectoris: a 3-year follow-up. Coron Artery Dis 2012; 23: 330–336.22735091

18.

Sun

XP.

Chen

WM.

Sun

et al. Impact of red blood cell distribution width on long-term mortality in patients with ST-elevation myocardial infarction. Cardiology 2014; 128: 343–348.24970296

19.

Ertaş

Aydin

Sönmez

et al. Red cell distribution width predicts new-onset atrial fibrillation after coronary artery bypass grafting. Scand Cardiovasc J 2013; 47: 132–135.23035619

20.

Korantzopoulos

Sontis

Liu

et al. Association between red blood cell distribution width and postoperative atrial fibrillation after cardiac surgery: a pilot observational study. Int J Cardiol 2015; 185: 19–21.25777283

21.

Reinhart

WH.

Piety

NZ.

Goede

et al. Effect of osmolality on erythrocyte rheology and perfusion of an artificial microvascular network. Microvasc Res 2015; 98: 102–107.25660474

22.

Zhou

Tang

. Red blood cell distribution width: a novel predictive indicator for cardiovascular and cerebrovascular diseases. Dis Markers 2017; 2017: 1–23.29038615

23.

Pierce

CN.

Larson

. Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device. Perfusion 2005; 20: 83–90.15918445

24.

Adamsson Eryd

Borné

Melander

et al. Red blood cell distribution width is associated with incidence of atrial fibrillation. J Intern Med 2014; 275: 84–92.24112470

25.

Ryan

. Examination of the blood. In: Lichtman

MA.

Beutler

Kipps

TJ.

, et al. (eds) Williams Hematology. 7th edition. New York: McGraw-Hill, 2005.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

2.09 MB